Jatenzo Capsule, Liquid Filled
FDA Label NDC 69087-237

39 label sections · Submitted to the FDA by Tolmar Inc. · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Tolmar Inc. for the product Jatenzo (NDC 69087-237). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding recent major changes, 1 indications and usage, 2.1 confirmation of hypogonadism before initiation of jatenzo, 2.2 dosing and dose adjustment information, 3 dosage forms and strengths, 4 contraindications, 5.1 polycythemia, 5.2 venous thromboembolism, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.